Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
D001780:Blood Coagulation Tests; D001800:Blood Specimen Collection; D019411:Clinical Laboratory Techniques; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods* / Q000592:standards; D010958:Plasminogen / Q000032:analysis; D013300:Streptokinase / Q000494:pharmacology / Q000627:therapeutic use; D013927:Thrombosis / Q000175:diagnosis; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use
D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D005340:Fibrinogen; D010958:Plasminogen; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator